American International Group’s Applied Therapeutics APLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-8,793
Closed -$19K 3096
2022
Q1
$19K Sell
8,793
-620
-7% -$1.66K ﹤0.01% 3032
2021
Q4
$84K Sell
9,413
-281
-3% -$3.69K ﹤0.01% 2791
2021
Q3
$161K Sell
9,694
-231
-2% -$3.99K ﹤0.01% 2559
2021
Q2
$206 Buy
9,925
+901
+10% +$17.1K ﹤0.01% 2485
2021
Q1
$169 Buy
9,024
+1,104
+14% +$23.8K ﹤0.01% 2450
2020
Q4
$174 Sell
7,920
-227
-3% -$4.73K ﹤0.01% 2354
2020
Q3
$169K Sell
8,147
-13
-0.2% -$338 ﹤0.01% 2230
2020
Q2
$295K Buy
8,160
+3,341
+69% +$140K ﹤0.01% 1885
2020
Q1
$158K Buy
4,819
+810
+20% +$32.8K ﹤0.01% 2036
2019
Q4
$109K Buy
4,009
+2,735
+215% +$46.9K ﹤0.01% 2571
2019
Q3
$14K Buy
+1,274
New +$12K ﹤0.01% 3050

Other funds holding APLT

American International Group's APLT Position: Q2 2022 in Review

American International Group sold out of Applied Therapeutics (APLT) in Q2 2022, closing a stake of 8,793 shares — an estimated $19K sold.

American International Group first reported a position in APLT in Q3 2019 and held it in 11 quarters. The position peaked at $295K in Q2 2020. 53 funds tracked by Wall St. Rank hold APLT as of Q2 2022.

  • American International Group reported no remaining Applied Therapeutics position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 8,793 Applied Therapeutics shares in Q2 2022, an estimated $19K.
  • American International Group first reported a position in Applied Therapeutics in Q3 2019 and held it in 11 quarters.
  • American International Group's Applied Therapeutics position peaked at $295K in Q2 2020.
  • 53 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.